select search filters
roundups & rapid reactions
before the headlines
Fiona fox's blog

Moderna Q&A on their interim data on their omicron-containing bivalent vaccine

Today, Moderna have published in a press release their interim top-line findings looking at antibody responses from their Omicron-containing bivalent COVID-19 vaccine.

Journalists dialled into the briefing to hear from Moderna scientists and ask them questions.

This was interim early data with no paper or preprint.


Speakers included:

Dr Philip Cruz, UK Medical Director, Moderna

Dr Paul Burton, Chief Medical Officer, Moderna


This Briefing was accompanied by an SMC Roundup of Comments.

in this section

filter Briefings by year

search by tag